What Glooko Diabetes AI does
Glooko aggregates data from CGMs, insulin pumps, and fitness trackers to provide AI insights for diabetes management. The AI identifies patterns in glucose data and suggests personalized recommendations to improve control.
Glooko Diabetes AI is a healthcare tool on Falcoscan. AI diabetes management platform for connected devices. Falcoscan rates Glooko Diabetes AI with an Opportunity score of 82/100, a Saturation score of 10/100, and a Wrapper-risk score of 10/100. Market signal: hot. Glooko Diabetes AI is founded in 2012, currently at Series_a stage. Pricing: Paid. Falcoscan rating 4.4/5.